Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche Holding AG

http://www.roche.com

Latest From Roche Holding AG

BioMarin Rolls Up Sleeves To Prepare For Roctavian’s EU Debut

The company plans to start in Germany with an outcomes-based payment model. But while a US FDA nod seems likely, analysts have been more cautious about calling US approval a done deal.

Gene Therapy Market Access

Sarepta’s Exondys 51 Successor On Clinical Hold, But Quick Resolution Expected

The FDA placed a hold on the Phase II study of SRP-5051, which uses the company’s next-generation peptide conjugation technology, but Sarepta thinks it can address safety questions in short order.

Drug Safety Clinical Trials

Novartis Scores Its First Tumor-Agnostic Label For Two Nearly Decade-Old Cancer Drugs

The FDA approved Tafinlar/Mekinist for BRAF V600E-mutated solid tumors, based in part on a Phase II basket trial studying more than two dozen drugs across dozens of cancers based on genetic testing.

Approvals Cancer

England Rejects Funding For Kimmtrak, Onureg & Minjuvi But Says Yes To Idefirix, Evrenzo & Verzenios

Immunocore’s advanced uveal melanoma drug, Kimmtrak, and Hansa’s Idefirix for increasing the chances of a successful kidney transplant are among the latest treatments that NICE has appraised regarding their cost-effectiveness.

United Kingdom Cost Effectiveness
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Other Names / Subsidiaries
    • Adheron Therapeutics
    • Anadys Pharmaceuticals, Inc.
    • Ariosa Diagnostics
    • Arius Research, Inc.
    • Boehringer Mannheim
    • CAPP Medical
    • Chugai Pharmaceutical Co., Ltd.
    • Dutalys GmbH
    • Flatiron Health
    • Foundation Medicine
    • GenMark Diagnostics, Inc.
    • Genentech Inc.
    • GeneWEAVE BioSciences, Inc.
    • Genia Technologies, Inc.
    • GlycArt Biotechnology
    • Hoffmann-La Roche
    • Inflazome Ltd.
    • Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
    • NexDx, Inc.)
    • Inception 5
    • InterMune, Inc.
    • Inflazome Ltd.
    • IQuum, Inc.
    • Jecure Therapeutics
    • Kapa Biosystems, Inc.
    • Marcadia Biotech, Inc.
    • Medingo Ltd.
    • Memory Pharmaceuticals Corporation
    • mtm laboratories AG
    • Piramed Pharma
    • Santaris Pharma A/S
    • Seragon Pharmaceuticals
    • Signature Diagnostics AG
    • Stratos Genomics
    • Syntex Corporation
    • Tanox, Inc.
    • Tensha Therapeutics, Trophos SA
    • Ventana Medical Systems, Inc.
    • Viewics, Inc.
UsernamePublicRestriction

Register